HEADER MEMBRANE PROTEIN 10-FEB-21 7LOI TITLE MODEL OF THE HIV-1 GP41 MEMBRANE-PROXIMAL EXTERNAL REGION, TITLE 2 TRANSMEMBRANE DOMAIN AND CYTOPLASMIC TAIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSMEMBRANE PROTEIN GP41; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: TM, GLYCOPROTEIN 41, GP41; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: ENV; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PMM-LR6 KEYWDS MPER, TMD, CT, MEMBRANE-PROXIMAL EXTERNAL REGION, TRANSMEMBRANE KEYWDS 2 DOMAIN, CYTOPLASMIC TAIL, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR A.PIAI,Q.FU,A.K.SHARP,B.BIGHI,A.M.BROWN,J.J.CHOU REVDAT 5 15-MAY-24 7LOI 1 REMARK REVDAT 4 14-JUN-23 7LOI 1 REMARK REVDAT 3 19-MAY-21 7LOI 1 JRNL REVDAT 2 05-MAY-21 7LOI 1 JRNL REVDAT 1 28-APR-21 7LOI 0 JRNL AUTH A.PIAI,Q.FU,A.K.SHARP,B.BIGHI,A.M.BROWN,J.J.CHOU JRNL TITL NMR MODEL OF THE ENTIRE MEMBRANE-INTERACTING REGION OF THE JRNL TITL 2 HIV-1 FUSION PROTEIN AND ITS PERTURBATION OF MEMBRANE JRNL TITL 3 MORPHOLOGY. JRNL REF J.AM.CHEM.SOC. V. 143 6609 2021 JRNL REFN ESSN 1520-5126 JRNL PMID 33882664 JRNL DOI 10.1021/JACS.1C01762 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LOI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254753. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.2 MM [U-100% 13C; U-100% 15N; REMARK 210 U-85% 2H] HIV-1 GP41 MPER-TMD-CT, REMARK 210 40 MM DMPC, 80 MM DHPC, 40 MM REMARK 210 MES, 1 % SODIUM AZIDE, 90% H2O/ REMARK 210 10% D2O; 1 MM [ILV-100% 13C; U- REMARK 210 100% 15N; U-85% 2H] HIV-1 GP41 REMARK 210 MPER-TMD-CT, 40 MM DMPC, 80 MM REMARK 210 DHPC, 40 MM MES, 1 % SODIUM REMARK 210 AZIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N TROSY HSQC; 3D TROSY REMARK 210 HNCO; 3D TROSY HNCA; 2D 1H-13C REMARK 210 HSQC; 3D 15N-EDITED NOESY-TROSY- REMARK 210 HSQC; 3D 13C-EDITED NOESY; 3D REMARK 210 15N-EDITED TROSY-NOESY-TROSY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, CARA, XEASY, X REMARK 210 -PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 PHE A 717 REMARK 465 GLN A 718 REMARK 465 THR A 719 REMARK 465 HIS A 720 REMARK 465 LEU A 721 REMARK 465 PRO A 722 REMARK 465 THR A 723 REMARK 465 PRO A 724 REMARK 465 ARG A 725 REMARK 465 GLY A 726 REMARK 465 PRO A 727 REMARK 465 ASP A 728 REMARK 465 ARG A 729 REMARK 465 PRO A 730 REMARK 465 GLU A 731 REMARK 465 GLY A 732 REMARK 465 ILE A 733 REMARK 465 GLU A 734 REMARK 465 GLU A 735 REMARK 465 GLU A 736 REMARK 465 GLY A 737 REMARK 465 GLY A 738 REMARK 465 PHE B 717 REMARK 465 GLN B 718 REMARK 465 THR B 719 REMARK 465 HIS B 720 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 THR B 723 REMARK 465 PRO B 724 REMARK 465 ARG B 725 REMARK 465 GLY B 726 REMARK 465 PRO B 727 REMARK 465 ASP B 728 REMARK 465 ARG B 729 REMARK 465 PRO B 730 REMARK 465 GLU B 731 REMARK 465 GLY B 732 REMARK 465 ILE B 733 REMARK 465 GLU B 734 REMARK 465 GLU B 735 REMARK 465 GLU B 736 REMARK 465 GLY B 737 REMARK 465 GLY B 738 REMARK 465 PHE C 717 REMARK 465 GLN C 718 REMARK 465 THR C 719 REMARK 465 HIS C 720 REMARK 465 LEU C 721 REMARK 465 PRO C 722 REMARK 465 THR C 723 REMARK 465 PRO C 724 REMARK 465 ARG C 725 REMARK 465 GLY C 726 REMARK 465 PRO C 727 REMARK 465 ASP C 728 REMARK 465 ARG C 729 REMARK 465 PRO C 730 REMARK 465 GLU C 731 REMARK 465 GLY C 732 REMARK 465 ILE C 733 REMARK 465 GLU C 734 REMARK 465 GLU C 735 REMARK 465 GLU C 736 REMARK 465 GLY C 737 REMARK 465 GLY C 738 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 4 TYR A 795 CB - CG - CD1 ANGL. DEV. = -4.3 DEGREES REMARK 500 6 TYR B 795 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 662 151.31 179.61 REMARK 500 1 TRP A 672 44.75 -104.08 REMARK 500 1 PHE A 673 77.64 -59.57 REMARK 500 1 ASP A 674 -72.02 -163.76 REMARK 500 1 TYR A 712 -74.60 -63.53 REMARK 500 1 PRO A 714 -112.59 -11.86 REMARK 500 1 ASP A 741 -6.26 -52.22 REMARK 500 1 LEU A 765 162.74 62.12 REMARK 500 1 TYR A 768 164.89 58.16 REMARK 500 1 HIS A 769 -19.51 81.06 REMARK 500 1 GLU A 791 -9.59 -51.85 REMARK 500 1 GLU A 824 -71.10 68.10 REMARK 500 1 ARG A 846 108.21 -46.46 REMARK 500 1 LEU B 661 -154.70 46.14 REMARK 500 1 GLU B 662 -168.84 57.18 REMARK 500 1 LEU B 663 -35.50 -39.03 REMARK 500 1 TRP B 672 34.93 -94.01 REMARK 500 1 PHE B 673 -51.06 -22.19 REMARK 500 1 PRO B 714 164.21 -33.61 REMARK 500 1 LEU B 765 -173.55 50.11 REMARK 500 1 PHE B 766 45.70 -71.15 REMARK 500 1 SER B 767 145.08 -171.58 REMARK 500 1 HIS B 769 -19.12 79.50 REMARK 500 1 GLU B 824 16.94 55.51 REMARK 500 1 LEU C 661 -169.34 -57.88 REMARK 500 1 PHE C 673 -70.81 67.10 REMARK 500 1 ASP C 674 19.87 -156.80 REMARK 500 1 TYR C 681 -40.09 -135.24 REMARK 500 1 TYR C 712 -70.65 -173.02 REMARK 500 1 PRO C 714 -99.74 -19.59 REMARK 500 1 LEU C 765 117.40 53.99 REMARK 500 1 PHE C 766 145.55 61.18 REMARK 500 1 SER C 767 -159.68 45.49 REMARK 500 1 TYR C 768 -4.99 -143.69 REMARK 500 1 ALA C 821 -19.36 -47.80 REMARK 500 1 ILE C 843 -50.78 -149.25 REMARK 500 1 ARG C 846 61.36 60.09 REMARK 500 2 GLU A 662 -173.51 -173.26 REMARK 500 2 PHE A 673 23.52 46.09 REMARK 500 2 ASP A 674 -72.82 -119.90 REMARK 500 2 TYR A 712 -72.64 -142.17 REMARK 500 2 PRO A 714 -117.88 -8.76 REMARK 500 2 ASP A 741 -5.73 -52.32 REMARK 500 2 LEU A 765 167.13 56.53 REMARK 500 2 SER A 767 90.34 55.30 REMARK 500 2 TYR A 768 -176.31 -54.78 REMARK 500 2 HIS A 769 -13.31 83.49 REMARK 500 2 VAL A 822 -47.75 -148.64 REMARK 500 2 ILE A 843 89.17 42.54 REMARK 500 2 ARG A 845 -42.28 -134.65 REMARK 500 REMARK 500 THIS ENTRY HAS 577 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 8 ARG B 770 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30856 RELATED DB: BMRB REMARK 900 MODEL OF THE HIV-1 GP41 MEMBRANE-PROXIMAL EXTERNAL REGION, REMARK 900 TRANSMEMBRANE DOMAIN AND CYTOPLASMIC TAIL DBREF1 7LOI A 660 856 UNP A0A386YSI0_9HIV1 DBREF2 7LOI A A0A386YSI0 665 861 DBREF1 7LOI B 660 856 UNP A0A386YSI0_9HIV1 DBREF2 7LOI B A0A386YSI0 665 861 DBREF1 7LOI C 660 856 UNP A0A386YSI0_9HIV1 DBREF2 7LOI C A0A386YSI0 665 861 SEQADV 7LOI ASP A 674 UNP A0A386YSI ASN 679 CONFLICT SEQADV 7LOI ARG A 683 UNP A0A386YSI LYS 688 CONFLICT SEQADV 7LOI ILE A 687 UNP A0A386YSI MET 692 CONFLICT SEQADV 7LOI SER A 691 UNP A0A386YSI GLY 696 CONFLICT SEQADV 7LOI ILE A 693 UNP A0A386YSI VAL 698 CONFLICT SEQADV 7LOI LEU A 704 UNP A0A386YSI ILE 709 CONFLICT SEQADV 7LOI SER A 764 UNP A0A386YSI CYS 769 ENGINEERED MUTATION SEQADV 7LOI GLY A 823 UNP A0A386YSI ALA 828 ENGINEERED MUTATION SEQADV 7LOI SER A 837 UNP A0A386YSI CYS 842 ENGINEERED MUTATION SEQADV 7LOI ASP B 674 UNP A0A386YSI ASN 679 CONFLICT SEQADV 7LOI ARG B 683 UNP A0A386YSI LYS 688 CONFLICT SEQADV 7LOI ILE B 687 UNP A0A386YSI MET 692 CONFLICT SEQADV 7LOI SER B 691 UNP A0A386YSI GLY 696 CONFLICT SEQADV 7LOI ILE B 693 UNP A0A386YSI VAL 698 CONFLICT SEQADV 7LOI LEU B 704 UNP A0A386YSI ILE 709 CONFLICT SEQADV 7LOI SER B 764 UNP A0A386YSI CYS 769 ENGINEERED MUTATION SEQADV 7LOI GLY B 823 UNP A0A386YSI ALA 828 ENGINEERED MUTATION SEQADV 7LOI SER B 837 UNP A0A386YSI CYS 842 ENGINEERED MUTATION SEQADV 7LOI ASP C 674 UNP A0A386YSI ASN 679 CONFLICT SEQADV 7LOI ARG C 683 UNP A0A386YSI LYS 688 CONFLICT SEQADV 7LOI ILE C 687 UNP A0A386YSI MET 692 CONFLICT SEQADV 7LOI SER C 691 UNP A0A386YSI GLY 696 CONFLICT SEQADV 7LOI ILE C 693 UNP A0A386YSI VAL 698 CONFLICT SEQADV 7LOI LEU C 704 UNP A0A386YSI ILE 709 CONFLICT SEQADV 7LOI SER C 764 UNP A0A386YSI CYS 769 ENGINEERED MUTATION SEQADV 7LOI GLY C 823 UNP A0A386YSI ALA 828 ENGINEERED MUTATION SEQADV 7LOI SER C 837 UNP A0A386YSI CYS 842 ENGINEERED MUTATION SEQRES 1 A 197 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 A 197 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 A 197 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 A 197 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 A 197 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 A 197 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 A 197 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 A 197 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 A 197 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 A 197 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG GLY SEQRES 11 A 197 TRP GLU ALA LEU LYS TYR TRP TRP ASN LEU LEU GLN TYR SEQRES 12 A 197 TRP SER GLN GLU LEU LYS ASN SER ALA VAL SER LEU LEU SEQRES 13 A 197 ASN ALA THR ALA ILE ALA VAL GLY GLU GLY THR ASP ARG SEQRES 14 A 197 VAL ILE GLU VAL VAL GLN GLY ALA SER ARG ALA ILE ARG SEQRES 15 A 197 HIS ILE PRO ARG ARG ILE ARG GLN GLY LEU GLU ARG ILE SEQRES 16 A 197 LEU LEU SEQRES 1 B 197 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 B 197 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 B 197 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 B 197 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 B 197 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 B 197 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 B 197 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 B 197 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 B 197 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 B 197 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG GLY SEQRES 11 B 197 TRP GLU ALA LEU LYS TYR TRP TRP ASN LEU LEU GLN TYR SEQRES 12 B 197 TRP SER GLN GLU LEU LYS ASN SER ALA VAL SER LEU LEU SEQRES 13 B 197 ASN ALA THR ALA ILE ALA VAL GLY GLU GLY THR ASP ARG SEQRES 14 B 197 VAL ILE GLU VAL VAL GLN GLY ALA SER ARG ALA ILE ARG SEQRES 15 B 197 HIS ILE PRO ARG ARG ILE ARG GLN GLY LEU GLU ARG ILE SEQRES 16 B 197 LEU LEU SEQRES 1 C 197 LEU LEU GLU LEU ASP LYS TRP ALA SER LEU TRP ASN TRP SEQRES 2 C 197 PHE ASP ILE THR ASN TRP LEU TRP TYR ILE ARG ILE PHE SEQRES 3 C 197 ILE ILE ILE VAL GLY SER LEU ILE GLY LEU ARG ILE VAL SEQRES 4 C 197 PHE ALA VAL LEU SER LEU VAL ASN ARG VAL ARG GLN GLY SEQRES 5 C 197 TYR SER PRO LEU SER PHE GLN THR HIS LEU PRO THR PRO SEQRES 6 C 197 ARG GLY PRO ASP ARG PRO GLU GLY ILE GLU GLU GLU GLY SEQRES 7 C 197 GLY GLU ARG ASP ARG ASP ARG SER ILE ARG LEU VAL ASN SEQRES 8 C 197 GLY SER LEU ALA LEU ILE TRP ASP ASP LEU ARG SER LEU SEQRES 9 C 197 SER LEU PHE SER TYR HIS ARG LEU ARG ASP LEU LEU LEU SEQRES 10 C 197 ILE VAL THR ARG ILE VAL GLU LEU LEU GLY ARG ARG GLY SEQRES 11 C 197 TRP GLU ALA LEU LYS TYR TRP TRP ASN LEU LEU GLN TYR SEQRES 12 C 197 TRP SER GLN GLU LEU LYS ASN SER ALA VAL SER LEU LEU SEQRES 13 C 197 ASN ALA THR ALA ILE ALA VAL GLY GLU GLY THR ASP ARG SEQRES 14 C 197 VAL ILE GLU VAL VAL GLN GLY ALA SER ARG ALA ILE ARG SEQRES 15 C 197 HIS ILE PRO ARG ARG ILE ARG GLN GLY LEU GLU ARG ILE SEQRES 16 C 197 LEU LEU HELIX 1 AA1 GLU A 662 TRP A 670 1 9 HELIX 2 AA2 ASP A 674 ILE A 697 1 24 HELIX 3 AA3 VAL A 698 GLN A 710 1 13 HELIX 4 AA4 ASP A 741 LEU A 748 1 8 HELIX 5 AA5 ASN A 750 SER A 764 1 15 HELIX 6 AA6 HIS A 769 ARG A 787 1 19 HELIX 7 AA7 TRP A 790 ALA A 821 1 32 HELIX 8 AA8 GLY A 825 ARG A 841 1 17 HELIX 9 AA9 ARG A 846 ILE A 854 1 9 HELIX 10 AB1 LEU B 661 TRP B 670 1 10 HELIX 11 AB2 TRP B 672 GLY B 711 1 40 HELIX 12 AB3 ARG B 740 LEU B 765 1 26 HELIX 13 AB4 HIS B 769 GLY B 789 1 21 HELIX 14 AB5 TRP B 790 ALA B 821 1 32 HELIX 15 AB6 GLY B 825 ILE B 843 1 19 HELIX 16 AB7 ARG B 846 LEU B 856 1 11 HELIX 17 AB8 GLU C 662 LEU C 669 1 8 HELIX 18 AB9 TRP C 670 TRP C 672 5 3 HELIX 19 AC1 ASP C 674 GLN C 710 1 37 HELIX 20 AC2 ARG C 740 ARG C 747 1 8 HELIX 21 AC3 ASN C 750 SER C 764 1 15 HELIX 22 AC4 HIS C 769 GLY C 789 1 21 HELIX 23 AC5 TRP C 790 ALA C 821 1 32 HELIX 24 AC6 GLY C 825 HIS C 842 1 18 HELIX 25 AC7 ARG C 846 ILE C 854 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1